Litcius/Paper detail

Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial

Karim Fizazi, Ken Herrmann, Bernd J. Krause, Kambiz Rahbar, Kim N., Michael J. Morris, Oliver Sartor, Scott T. Tagawa, A. Tuba Kendi, Nicholas J. Vogelzang, Jérémie Calais, James Nagarajah, Xiao X. Wei, Vadim S. Koshkin, Jean‐Mathieu Beauregard, Brian Chang, Ray Ghouse, Michelle DeSilvio, Richard A. Messmann, Johann S. de Bono

2023The Lancet Oncology109 citationsDOIOpen Access PDF

Topics & Concepts

MedicineProstate cancerGlutamate carboxypeptidase IIRadioligandQuality of life (healthcare)OncologyInternal medicineLutetiumCancerNursingReceptorOrganic chemistryOxideChemistryYttriumProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment